NCT05507255

Brief Summary

The aim of this study will be to investigate the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

4 months

First QC Date

August 16, 2022

Last Update Submit

June 26, 2023

Conditions

Keywords

Aerobic exerciseRelaxation trainingDiurnal cortisol patternPremenstrual syndrome

Outcome Measures

Primary Outcomes (2)

  • Diurnal cortisol pattern

    It will be evaluated through calculating the ratio of morning cortisol level to evening cortisol level for all participants at baseline and after 8 weeks of treatment.

    8 weeks

  • Severity of premenstrual symptoms

    Severity of premenstrual symptoms of all participants will be measured through daily record of severity of problems (DRSP) at baseline and after 8 weeks of treatment.

    8 weeks

Study Arms (2)

Relaxation training

ACTIVE COMPARATOR

Females will receive relaxation training, in the form of deep breathing, 3 days per week, for 8 weeks.

Other: Relaxation training

The same relaxation training plus an aerobic exercise program

EXPERIMENTAL

Females will receive the same relaxation training, in addition to 30 minutes of a moderate aerobic exercise program on a treadmill, 3 days per week, for 8 weeks.

Other: Relaxation trainingOther: An aerobic exercise program

Interventions

Relaxation training in the form of deep breathing exercises

Relaxation trainingThe same relaxation training plus an aerobic exercise program

An aerobic exercise program of a moderate intensity, based on the target heart rate (THR) that will be calculated in accordance with Karvonen's equation, using resting heart rate (HRrest), maximal heart rate (HRmax) and training fraction. THR = HRrest (bpm) + (HRmax (bpm) - HRrest (bpm)) × training fraction.The exercise session will have three phases, warming up, active phase and cooling down.

The same relaxation training plus an aerobic exercise program

Eligibility Criteria

Age18 Years - 23 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sedentary, virginal, adult, non-smoker females suffering from premenstrual syndrome.
  • They should have regular menstrual cycles (cycles of 21-35 days with a bleeding time of 3-10 days)
  • They should have the following criteria in daily record of severity of problems in at least one of two consecutive menstrual cycles prior to treatment starting to confirm premenstrual syndrome diagnosis: a) more than three items have an average score over 3 during the luteal phase, and b) a luteal phase score is 30% more than a follicular phase score.
  • No traumatic life events in the last 2 months before starting the study.
  • Their age will be 18-23 years
  • Their body mass index (BMI) will be less than 30 kg/m2.

You may not qualify if:

  • Menstrual problems (e.g. menorrhagia, metrorhagia and polycystic ovary disease).
  • Cardio-respiratory, renal, neurological and pelvic inflammatory diseases, tumors, infections, anemia, diabetes, hypertension, asthma, rheumatoid arthritis, headache, migraine, thyroid or mental disorders.
  • Participation at any other exercise training program during this study.
  • Receiving any kind of medications, hormonal treatment or supplementation (vitamin, mineral or herbal supplement).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical therapy, Cairo University

Giza, Egypt

Location

MeSH Terms

Conditions

Premenstrual Syndrome

Interventions

Relaxation Therapy

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Doaa Osman

    Department of Physical Therapy for Woman's Health, Faculty of physical therapy, Cairo University, Giza, Egypt.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Random generator
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 18, 2022

Study Start

February 1, 2023

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

June 27, 2023

Record last verified: 2023-06

Locations